A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma

Cellular immunotherapy is emerging as a potential immunotherapeutic modality in multiple myeloma (MM). We have developed potent immunotherapeutic agent (VAX-DC/MM) generated by dendritic cells (DCs) loaded with autologous myeloma cells irradiated with ultraviolet B. In this study, we evaluated the s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Jung, Sung-Hoon, Lee, Hyun-Ju, Lee, Youn-Kyung, Yang, Deok-Hwan, Kim, Hyeoung-Joon, Rhee, Joon Haeng, Emmrich, Frank, Lee, Je-Jung
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Clinical Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5522196/
https://ncbi.nlm.nih.gov/pubmed/28088784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14582
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados